Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ghrelin in chronic liver disease.

Frank Tacke1, Georg Brabant, Elmar Kruck

  • 1Department of Gastroenterology, Hepatology and Endocrinology, Hannover Medical School, Carl-Neuberg-Strasse 1, 30625 Hannover, Germany.

Journal of Hepatology
|March 29, 2003
PubMed
Summary

Ghrelin levels are elevated in chronic liver disease (CLD) patients, correlating with complications but not liver function. Insulin-like growth factor-1 (IGF-1) is reduced, inversely correlating with disease severity.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Zeitschrift fur Gastroenterologie·2021
Same author

Granulocyte-colony stimulating factor (G-CSF) to treat acute-on-chronic liver failure: A multicenter randomized trial (GRAFT study).

Journal of hepatology·2021
Same author

Hypothermic Oxygenated Machine Perfusion Reduces Early Allograft Injury and Improves Post-transplant Outcomes in Extended Criteria Donation Liver Transplantation From Donation After Brain Death: Results From a Multicenter Randomized Controlled Trial (HOPE ECD-DBD).

Annals of surgery·2021
Same author

Upregulation of Anti-Oxidative Stress Response Improves Metabolic Changes in L-Selectin-Deficient Mice but Does Not Prevent NAFLD Progression or Fecal Microbiota Shifts.

International journal of molecular sciences·2021
Same author

A genome-first approach to mortality and metabolic phenotypes in <i>MTARC1</i> p.Ala165Thr (rs2642438) heterozygotes and homozygotes.

Med (New York, N.Y.)·2021
Same author

Macrophage migration inhibitory factor exerts pro-proliferative and anti-apoptotic effects via CD74 in murine hepatocellular carcinoma.

British journal of pharmacology·2021

Area of Science:

  • Endocrinology
  • Hepatology
  • Metabolic Research

Background:

  • Ghrelin, a ligand for the growth hormone secretagogue receptor, influences energy metabolism, glucose homeostasis, and food intake.
  • Insulin-like growth factor-1 (IGF-1) is a key mediator of the growth hormone (GH) axis.
  • Chronic liver diseases (CLD) involve complex metabolic and endocrine dysregulations.

Purpose of the Study:

  • To investigate the roles of ghrelin and IGF-1 in patients diagnosed with chronic liver diseases (CLD).
  • To correlate serum levels of ghrelin and IGF-1 with clinical and biochemical parameters in CLD patients.

Main Methods:

  • Serum ghrelin and IGF-1 levels were quantified in 105 CLD patients and 97 healthy controls.
  • Measurements were correlated with clinical classifications (e.g., Child's classification) and biochemical markers.

Related Experiment Videos

Main Results:

  • CLD patients exhibited significantly elevated ghrelin and reduced IGF-1 levels compared to controls.
  • IGF-1 levels showed an inverse correlation with Child's classification, indicating reduced levels in more severe disease.
  • Ghrelin was elevated in Child C cirrhosis patients irrespective of liver disease etiology and correlated with CLD complications (ascites, bleeding, encephalopathy, anemia, renal dysfunction) but not directly with liver function.

Conclusions:

  • Ghrelin levels increase with cirrhosis severity and complications in CLD, unlike IGF-1, which correlates with disease stage.
  • The inverse correlation between ghrelin and alpha-fetoprotein (AFP) in hepatocellular carcinoma (HCC) patients warrants further investigation.
  • Ghrelin's role in the pathogenesis of anorexia-cachexia syndrome in CLD warrants further study.